Bruker Daltonics-Sponsored American Chemical Society Award for Outstanding Achievement in Mass Spectrometry Goes to Rockefeller University Professor.Business Editors and Health/Medical Writers BIOWIRE2K BILLERICA, Mass.--(BW HealthWire)--April 9, 2002 Bruker Daltonics Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BDAL) today said that the American Chemical Society's Frank H. Field and Joe L. Franklin Award for Outstanding Achievement in Mass Spectrometry, sponsored annually by Bruker Daltonics, was awarded to Dr. Brian T. Chait, Camille and Henry Dreyfus Professor at Rockefeller University, New York, NY during an ACS (Asynchronous Communications Server) See network access server. awards ceremony. Dr. Chait is head of the Laboratory of Mass Spectrometry and Gaseous Ion Chemistry at Rockefeller University, where he is developing new mass spectrometric tools for studying biological processes involving proteins. His laboratory's basic research focuses on investigations of new techniques for volatilizing and ionizing proteins and bioinformatics for the identification of proteins and protein structures. Professor Chait and his research associates also design and construct mass spectrometric-based methodology to assist in the solution of challenging biological problems. These tools are applied to the solution of biological problems that involve, for example, the rapid identification of proteins, the elucidation of posttranslational modifications and the definition of sites of functional interaction between biomolecules This page aims to list articles on Wikipedia that describe particular biomolecules or types of biomolecules. This list is not necessarily complete or up to date - if you see an article that should be here but isn't (or one that shouldn't be here but is), please update the page . Professor Chait publishes widely, including 2002 contributions to Nature, Protein Science, Journal of the American Society for Mass Spectrometry The Journal of the American Society for Mass Spectrometry (usually abbreviated as J. Am. Soc. Mass Spectrom. or JASMS), is a peer-reviewed scientific journal published since 1990 by Elsevier. , and the Journal of Biological Chemistry The Journal of Biological Chemistry (often abbreviated JBC) is a scientific journal founded in 1905 and published since 1925 by the American Society for Biochemistry and Molecular Biology. . Dr. John Wronka, Vice President of Bruker Daltonics, expressed excitement about the award: "Bruker Daltonics has long striven to encourage and further the development of mass spectrometry in life-science applications. Dr Chait's work has been crucial to the development and acceptance of both the MALDI MALDI Matrix-Assisted Laser Desorption/Ionization and electrospray ionization techniques that are key to the growth of life science research using MS. We are proud to sponsor this annual award, and especially pleased with the selection of Dr. Chait." The annual award was presented by Dr. Timothy Alavosus, Marketing Director of Bruker Daltonics. ABOUT BRUKER DALTONICS Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. For more information about Bruker Daltonics, please visit www.bdal.com. CAUTIONARY STATEMENT Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to technological approaches, product development, manufacturing, market acceptance, cost and pricing of Bruker Daltonics' products, dependence on collaborative partners, suppliers, FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. and other risk factors discussed from time to time in Bruker Daltonics' reports or filings with the Securities and Exchange Commission. Bruker Daltonics expressly disclaims any obligation to update the information contained herein. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion